Department of Defense Driving Mass Vaccination While FDA and Vaccine Companies are Powerless to Stop It

Quoted from the DARPA website: “As part of the ADEPT program in 2011, DARPA began investing in nucleic acid vaccines. The hypothesis was that rather than delivering antigens to the immune system, we could deliver genes that encode the antigen and allow the human body to produce the antigen from its own cells, triggering a protective immune response. In December 2020, former ADEPT performer Moderna’s RNA vaccine received FDA Emergency Use Authorization (EUA) approval for the prevention of COVID-19.”1

So, it is fully disclosed that the genetic vaccines were not a product of Operation Warp Speed and developed in just a few months, as portrayed by the White House. In truth, DARPA has been working on genetic vaccines with companies such as Moderna since 2011. What is the role of the FDA?2 Latypova points out it is largely “theatre”. In other words, the FDA is giving sham approvals to versions of the vaccines as they move forward since they are powerless to stop it.

https://www.americaoutloud.com/department-of-defense-driving-mass-vaccination-while-fda-and-vaccine-companies-are-powerless-to-stop-it/

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: